CXCL10 is a Tumor Microenvironment and Immune Infiltration Related Prognostic Biomarker in Pancreatic Adenocarcinoma
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CXCL10 is a Tumor Microenvironment and Immune Infiltration Related Prognostic Biomarker in Pancreatic Adenocarcinoma
Authors
Keywords
-
Journal
Frontiers in Molecular Biosciences
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-02-21
DOI
10.3389/fmolb.2021.611508
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tumour immune cell infiltration and survival after platinum-based chemotherapy in high-grade serous ovarian cancer subtypes: A gene expression-based computational study
- (2020) Rong Liu et al. EBioMedicine
- Using ESTIMATE algorithm to establish an 8-mRNA signature prognosis prediction system and identify immunocyte infiltration-related genes in Pancreatic adenocarcinoma
- (2020) Zibo Meng et al. Aging-US
- Targeting tumor microenvironment in ovarian cancer: Premise and promise
- (2020) Yuting Jiang et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- CXCL10 and CCL21 Promote Migration of Pancreatic Cancer Cells Toward Sensory Neurons and Neural Remodeling in Tumors in Mice, Associated With Pain in Patients
- (2020) Michael Hirth et al. GASTROENTEROLOGY
- Systemic dysfunction and plasticity of the immune macroenvironment in cancer models
- (2020) Breanna M. Allen et al. NATURE MEDICINE
- Microenvironmental Determinants of Pancreatic Cancer
- (2020) Elisabeth Hessmann et al. PHYSIOLOGICAL REVIEWS
- CXCL10 mediates breast cancer tamoxifen resistance and promotes estrogen-dependent and independent proliferation
- (2020) Xiuming Wu et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Immune landscape, evolution, hypoxia-mediated viral mimicry pathways and therapeutic potential in molecular subtypes of pancreatic neuroendocrine tumours
- (2020) Kate Young et al. GUT
- Risk Factors in Pancreatic Adenocarcinoma: the Interrelation with Familial History and Predictive Role on Survival
- (2020) Livia Petrusel et al. Journal of Gastrointestinal and Liver Diseases
- Early macrophage infiltrates impair pancreatic cancer cell growth by TNF-α secretion
- (2020) Cansu Tekin et al. BMC CANCER
- Tumor-stromal crosstalk in pancreatic cancer and tissue fibrosis
- (2019) Divya Thomas et al. Molecular Cancer
- Plasma IFN-γ-inducible chemokines CXCL9 and CXCL10 correlate with survival and chemotherapeutic efficacy in advanced pancreatic ductal adenocarcinoma
- (2019) Ling Qian et al. PANCREATOLOGY
- Tumour microenvironment of pancreatic cancer: immune landscape is dictated by molecular and histopathological features
- (2019) Eva Karamitopoulou BRITISH JOURNAL OF CANCER
- Development of immune checkpoint therapy for cancer
- (2019) Jill M. Fritz et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Exploiting vulnerabilities of cancer by targeting nuclear receptors of stromal cells in tumor microenvironment
- (2019) Hong Sheng Cheng et al. Molecular Cancer
- Stromal Microenvironment Shapes the Intratumoral Architecture of Pancreatic Cancer
- (2019) Matteo Ligorio et al. CELL
- Profiles of immune cell infiltration and immune-related genes in the tumor microenvironment of colorectal cancer
- (2019) Penglei Ge et al. BIOMEDICINE & PHARMACOTHERAPY
- Stromal-Immune Score-Based Gene Signature: A Prognosis Stratification Tool in Gastric Cancer
- (2019) Hao Wang et al. Frontiers in Oncology
- Development of primary human pancreatic cancer organoids, matched stromal and immune cells and 3D tumor microenvironment models
- (2018) Susan Tsai et al. BMC CANCER
- Increased Chromogranin A–Positive Hormone-Negative Cells in Chronic Pancreatitis
- (2018) Abu Saleh Md Moin et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Transcriptome-derived stromal and immune scores infer clinical outcomes of patients with cancer
- (2018) Wei Liu et al. Oncology Letters
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Natural Killer-derived exosomal miR-186 inhibits neuroblastoma growth and immune escape mechanisms.
- (2018) Paolo Neviani et al. CANCER RESEARCH
- Circulating regulatory T cell subsets predict overall survival of patients with unresectable pancreatic cancer
- (2017) Chen Liu et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Dectin 1 activation on macrophages by galectin 9 promotes pancreatic carcinoma and peritumoral immune tolerance
- (2017) Donnele Daley et al. NATURE MEDICINE
- Crosstalk between Regulatory T Cells and Tumor-Associated Dendritic Cells Negates Anti-tumor Immunity in Pancreatic Cancer
- (2017) Jung-Eun Jang et al. Cell Reports
- Cancer-FOXP3 directly activated CCL5 to recruit FOXP3+Treg cells in pancreatic ductal adenocarcinoma
- (2016) X Wang et al. ONCOGENE
- New horizons in tumor microenvironment biology: challenges and opportunities
- (2015) Fei Chen et al. BMC Medicine
- Downstream mediators of the intratumoral interferon response suppress antitumor immunity, induce gemcitabine resistance and associate with poor survival in human pancreatic cancer
- (2015) Daniel Delitto et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- IP-10/CXCL10 attracts regulatory T cells: Implication for pancreatic cancer
- (2015) Serena Lunardi et al. OncoImmunology
- Pancreatic cancer and its stroma: A conspiracy theory
- (2014) Zhihong Xu WORLD JOURNAL OF GASTROENTEROLOGY
- Chemokine (C–X–C motif) ligand (CXCL)10 in autoimmune diseases
- (2013) Alessandro Antonelli et al. AUTOIMMUNITY REVIEWS
- The immune network in pancreatic cancer development and progression
- (2013) S M Wörmann et al. ONCOGENE
- Review: The chemokine receptor CXCR3 and its ligands CXCL9, CXCL10 and CXCL11 in neuroimmunity - a tale of conflict and conundrum
- (2010) M. Müller et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search